Notre actualité
HCS Pharma is one of the winner of the Lab’StartUp village, organized by Forum Labo! As such, we have won a stand in the heart of the forum (March 26-28, 2019)… Thanks a lot to Read more…
Many news have been published since 2 or 3 years about Artificial Intelligence (AI) and Machine Learning / Deep Learning use in picture analysis. Lastly, Microsoft published an astonishing article where they explained that this Read more…
A new BIOMIMESYS® hydroscaffold is available for 3D cell culture! This hydroscaffold is suitable for neuronal cell culture. We tested it for two cell lines: SH-SY5Y cells, commonly used for pharmaceutical research, and LUHMES cells Read more…
Employeur : HCS Pharma Lieu de travail : Rennes Statut : Cadre Poste : Technico-commercial / Business Developer Rémunération : selon expérience Contexte HCS Pharma est une entreprise de services en biotechnologie créée en aout 2014, Read more…
Employeur : HCS Pharma Lieu de travail : Rennes Statut : Cadre Poste : Chef de projet cosmétologie / dermocosmétique Rémunération : selon expérience Contexte HCS Pharma est une entreprise de services en biotechnologie créée en Read more…
HCS Pharma team enjoyed attending BioFit 2018 and hosted events in Lille last week! Our business developer Nathalie had many fruitful BtoB meetings along the convention, and our study director Elodie could meet lots of Read more…
We are developing a new BIOMIMESYS® hydroscaffold for neuronal cells. First results are very promising because neurons grow and form neurites. Moreover cells lived longer than in monolayer culture. We are currently finalizing this new Read more…
We will be happy to meet you on Biofit, Lille, France, on December 4th & 5th, 2018 at the business convention or on our Booth D4/2 on Eurasanté/pole NSL Pavillion located at the center of Read more…
Our study directors Elodie and Pierre-Jean will attend “HI Europe” in Frankfurt next week. We cordially invite you to discuss with them, they will be happy to present our imaging services related to nutraceutical testing! We Read more…
This year, the ESTIV (European Society of Toxicology In Vitro) congress took place in Berlin and was again a very interesting symposium. The plenary session was open by a presentation on 3D models made by bioengineering Read more…
HCS Pharma will be present to the annual congress of the Society of Study of Blood-Brain Interfaces (SEISC) at Collège de France on Friday, November 9th 2018. The congress will begin by a plenary lecture Read more…
Last week we attended ELRIG UK Drug Discovery meeting in ExCeL London, and it was a great pleasure for us to present our poster about neurotoxicity testing using HCS there. Many interesting posters were displayed Read more…
Are your interested in meaning full images and high content analysis to asses your compounds properties ? Pierre-Jean, our dermocosmetic expert, will be present at Cosmetic 360 (the international trade fair for innovative ideas and Read more…
The 20th International Congress on In Vitro Toxicology (ESTIV2018) is coming and it will be a great occasion for HCS-Pharma to showcase our current co-development, with the institute du thorax of Nantes and the RHU Read more…
The 2018 Nobel Prize in Physiology or Medicine has been awarded to James Allisson and Tasuku Honjo for their research about immunotherapy to treat cancer. This therapeutic strategy is based on immune checkpoint targeting. Immune Read more…
In HCS Pharma we strongly believe that 3D is the right way to improve drugs dicovery processes. It’s why we develop our 3D hydroscaffold matrix BIOMIMESYS® for 3D cell culture and we invest in 3D Read more…
Our study director Elodie will attend Drug Discovery 2018 – THE ELRIG‘s flagship conference – which will take place in London next week! We are looking forward to presenting our poster about neurotoxicity testing. Don’t hesitate to visit Read more…
We are very happy to be highlighted by our partner Molecular Devices in this article : “HCS Pharma uses ImageXpress Micro Confocal Systems for phenotypic screening of physiologically relevant 3D cell models”. We have made a Read more…
Nos différents produits BIOMIMESYS® sont disponibles depuis le début de cette année et nous attachons beaucoup d’importance aux retours de nos clients, à leurs remarques et à leurs questions. Pour simplifier la communication avec notre Read more…
It is a great pleasure for us to welcome a new member in our scientific advisory board, Dr Samuel Meignan! He will for sure help us to develop relevant models related to oncology therapeutic area. Read more…
I was really pleased to participate in the kick-off meeting for the launch of NanoSTEM project, a European Marie Skłodowska-Curie Innovative Training Network (ITN) project, this summer. NanoSTEM is a multidisciplinary and innovative project including 11 Read more…
“Regulation needs to catch up with innovation.” Henry Paulson – CEO Goldman Sachs A very nice state of art about animal testing and its alternatives can be found in the new article “Animal Testing and its Read more…
Melanoma is a type of skin cancer that develops from cells called melanocytes, is one of the fastest-growing and deadliest cancer in the world. It usually caused by DNA damage resulting from exposure to ultraviolet Read more…